BCR and mantle cell lymphoma: B‐cell receptor (BCR) signaling constitutes the key proliferative driver and disease heterogeneity partly reflects distinct cells of origin: naïve‐like B cells are typically aggressive, whereas memory‐like B‐cell‐derived MCL follows a more indolent course.